These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18690564)

  • 1. Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure.
    Targoński R; Salczyńska D; Sadowski J; Cichowski L
    Kardiol Pol; 2008 Jul; 66(7):729-36; discussion 737-9. PubMed ID: 18690564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation.
    Watanabe T; Takeishi Y; Hirono O; Itoh M; Matsui M; Nakamura K; Tamada Y; Kubota I
    Heart Vessels; 2005 Mar; 20(2):45-9. PubMed ID: 15772777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period.
    Wozakowska-Kapłon B
    Int J Cardiol; 2005 May; 101(1):47-52. PubMed ID: 15860382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation.
    Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z
    Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly.
    Casaclang-Verzosa G; Barnes ME; Blume G; Seward JB; Gersh BJ; Cha SS; Bailey KR; Tsang TS
    Echocardiography; 2010 Apr; 27(4):394-9. PubMed ID: 20070356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M; Mori N; Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation.
    Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S110-4. PubMed ID: 15683475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of clinical risk factors of atrial fibrillation in congestive heart failure.
    Targoński R; Sadowski J; Romaszko J; Cichowski L
    Cardiol J; 2013; 20(4):364-9. PubMed ID: 23913454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study].
    Canpolat U; Oto A; Yorgun H; Sunman H; Şahiner L; Kaya EB; Özer N; Aytemir K
    Turk Kardiyol Dern Ars; 2015 Apr; 43(3):259-68. PubMed ID: 25905997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.
    Letsas KP; Weber R; Bürkle G; Mihas CC; Minners J; Kalusche D; Arentz T
    Europace; 2009 Feb; 11(2):158-63. PubMed ID: 19010799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.
    Korantzopoulos P; Kolettis TM; Kountouris E; Dimitroula V; Karanikis P; Pappa E; Siogas K; Goudevenos JA
    Int J Cardiol; 2005 Jul; 102(2):321-6. PubMed ID: 15982504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.
    Olshansky B; Heller EN; Mitchell LB; Chandler M; Slater W; Green M; Brodsky M; Barrell P; Greene HL
    J Am Coll Cardiol; 2005 Jun; 45(12):2026-33. PubMed ID: 15963405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial function in patients with a high C-reactive protein level and paroxysmal atrial fibrillation.
    Dernellis J; Panaretou M
    Acta Cardiol; 2006 Oct; 61(5):507-11. PubMed ID: 17117749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
    Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
    J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure.
    Kawabata M; Hirao K; Hachiya H; Higuchi K; Tanaka Y; Yagishita A; Inaba O; Isobe M
    J Cardiol; 2011 Sep; 58(2):108-15. PubMed ID: 21831597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure.
    Bonapace S; Rossi A; Cicoira M; Targher G; Marino P; Benfari G; Mugnai G; Arcaro G; Vassanelli C
    Echocardiography; 2016 Jul; 33(7):1024-31. PubMed ID: 27277158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical ablation of atrial fibrillation in patients with congestive heart failure.
    Grubitzsch H; Dushe S; Beholz S; Dohmen PM; Konertz W
    J Card Fail; 2007 Sep; 13(7):509-16. PubMed ID: 17826640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation.
    Knackstedt C; Gramley F; Schimpf T; Mischke K; Zarse M; Plisiene J; Schmid M; Lorenzen J; Frechen D; Neef P; Hanrath P; Kelm M; Schauerte P
    Cardiovasc Pathol; 2008; 17(5):318-24. PubMed ID: 18402824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.